Credit Suisse Ag Enzo Biochem Inc Transaction History

Credit Suisse Ag

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$2.61 - $4.08 $33,053 - $51,669	-12,664 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$1.82 - $2.61 $462 - $662	-254 Reduced 1.97%	12,664 $32,000
Q3 2020 Nov 13, 2020	BUY	$2.02 - $3.02 $26,094 - $39,012	12,918 New	12,918 $28,000
Q4 2019 Feb 12, 2020	SELL	$2.57 - $3.68 $35,137 - $50,312	-13,672 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$3.01 - $4.0 $3,371 - $4,480	-1,120 Reduced 7.57%	13,672 $49,000
Q2 2019 Aug 14, 2019	BUY	$2.79 - $4.31 $13,009 - $20,097	4,663 Added 46.04%	14,792 $50,000
Q1 2019 May 14, 2019	BUY	$2.54 - $4.02 $25,727 - $40,718	10,129 New	10,129 $27,000
Q3 2018 Nov 13, 2018	SELL	$3.81 - $5.53 $49,099 - $71,265	-12,887 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$5.06 - $6.78 $63,098 - $84,546	-12,470 Reduced 49.18%	12,887 $66,000
Q1 2018 May 15, 2018	BUY	$5.43 - $8.36 $64,812 - $99,784	11,936 Added 88.94%	25,357 $139,000
Q4 2017 Feb 14, 2018	SELL	$8.15 - $10.55 $150,946 - $195,396	-18,521 Reduced 57.98%	13,421 $110,000
Q3 2017 Nov 14, 2017	BUY	$10.45 - $11.44 $333,793 - $365,416	31,942	31,942 $334,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $33.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.